Portfolio Companies
7Epigenic Therapeutics
Epigenic Therapeutics raised $32M in Series A funding, led by Qiming Venture Partners.
XtalPi
AI drug discovery company XtalPi raises $400M in second major VC round within a year
Horizon Robotics
Chinese AI chip company rivals Nvidia, seeking funding round of over $700M
XPeng Inc.
XPeng Inc. raised $300M from Morningside Venture Capital, Simplicity Holding Limited, and others
XPeng
China's electric car start-up XPeng valued at 25 billion yuan in latest fundraising round
Xiaopeng
Electric-car maker Xiaopeng raises $587 million in funding round
XPENG Motors
XPENG Motors raises RMB 2.2 billion Series B funding for electric vehicle development and expansion.
Recent Articles
1826 Top Venture Capital Firms in Tech - Built In
An overview of the top 26 venture capital firms shaping the tech industry, highlighting key players that fund innovative startups and drive technological advancement.
5/22/2024
Epigenic Therapeutics Announces $32M in Series A Funding | Qiming Venture Partners - 启明创投
Epigenic Therapeutics has secured $32 million in Series A funding, with participation from Qiming Venture Partners, to advance its epigenetic-focused drug development programs.
8/30/2023
Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development - PR Newswire
Epigenic Therapeutics has secured $32 million in Series A funding to advance its breakthrough epigenome-based medicines into clinical development, marking a significant milestone in the emerging field of epigenetic therapeutics.
8/29/2023
Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy - PR Newswire
Epigenic Therapeutics has secured $20 million in Series Angel and Pre-A funding to advance its next generation gene editing therapy, marking a significant milestone in the biotechnology sector.
8/6/2022
5Y Capital did not respond to Risky Business report - Business and Human Rights Centre
5Y Capital failed to respond to the Risky Business report flagged by the Business and Human Rights Resource Centre, raising concerns over corporate accountability and human rights practices.
1/2/2022
Investigation takes stock of venture capital's human rights oversight, finding vast majority of firms are failing responsibilities & lacking diversity - Business and Human Rights Centre
A new investigation reveals that the vast majority of venture capital firms are failing to meet human rights responsibilities and lack diversity, raising concerns about ethical oversight in the investment sector.
9/22/2021
AI drug miner XtalPi strikes gold with $400M infusion, its 2nd VC megaround in a year - Fierce Biotech
XtalPi, an AI-driven drug discovery company, has secured a $400M funding round, marking its second major venture capital raise within a year, highlighting strong investor confidence in AI-powered pharmaceutical development.
8/13/2021
Who Is 5Y Capital? - The Wire China
An in-depth look at 5Y Capital, a prominent Chinese venture capital firm, exploring its origins, investment strategies, and influence in China's tech and startup ecosystem.
7/18/2021
5Y Capital, US$35b stakeholder in Kuaishou, to raise US$1b for start-ups - The Standard (HK)
5Y Capital, a major stakeholder in Chinese short-video platform Kuaishou valued at US$35 billion, plans to raise US$1 billion to invest in start-ups, signaling continued confidence in early-stage ventures.
2/18/2021
Horizon Robotics, a Chinese rival to Nvidia, seeks to raise over $700M - TechCrunch
Horizon Robotics, a Chinese AI chip company competing with Nvidia, is seeking to raise more than $700 million in funding to accelerate its development of autonomous driving and AI technologies.
12/21/2020
Chinese Venture Capital Firm Morningside Venture Capital Becomes 5Y Capital - Hubbis
Chinese venture capital firm Morningside Venture Capital has rebranded itself as 5Y Capital, marking a significant identity shift for one of China's prominent investment firms.
11/3/2020
VCJ 50 2020: Firms 11-50 - venturecapitaljournal.com
Venture Capital Journal ranks firms 11 through 50 in its annual VCJ 50 list for 2020, highlighting top venture capital firms based on their performance and investment activity.
11/2/2020
AI Drug R&D Startup XtalPi Announces Over 300 Million Series C Investment Led by SoftBank Vision Fund, PICC Capital, and Morningside - PR Newswire
AI-driven drug R&D startup XtalPi has secured over $300 million in Series C funding, led by SoftBank Vision Fund, PICC Capital, and Morningside, marking a major milestone in AI-powered pharmaceutical development.
9/28/2020
XPeng Inc. announced that it has received $300.000002 million in funding from Morningside Venture Capital, Simplicity Holding Limited, Guangzhou Huaduo Internet Technology Co., Ltd., and other investors - marketscreener.com
XPeng Inc. has secured approximately $300 million in funding from investors including Morningside Venture Capital, Simplicity Holding Limited, and Guangzhou Huaduo Internet Technology Co., Ltd., marking a significant capital raise for the Chinese EV maker.
12/1/2019
Electric-Car Maker Xiaopeng Raises $587 Million - Caixin Global
Chinese electric vehicle manufacturer Xiaopeng has successfully raised $587 million in fresh funding, signaling continued investor confidence in China's competitive EV market.
8/2/2018
China's electric car start-up XPeng valued at 25 billion yuan in latest fundraising - energy.economictimes.indiatimes.com
Chinese electric vehicle start-up XPeng has reached a valuation of 25 billion yuan in its latest fundraising round, highlighting growing investor confidence in China's EV sector.
8/2/2018
Watch Xiaomi Founder Lei Jun Is Top Entrepreneur, Morningside Venture Capital Says - Bloomberg.com
Morningside Venture Capital has named Xiaomi founder Lei Jun as a top entrepreneur, highlighting his leadership and business acumen in building one of China's most prominent tech companies.
7/9/2018
XPENG Motors Raises RMB 2.2 Billion Series B Capital Funding - FinSMEs
XPENG Motors has successfully raised RMB 2.2 billion in its Series B funding round, marking a significant milestone for the Chinese electric vehicle maker as it seeks to expand its operations and development.
1/30/2018
Investment Signals
3XPENG Motors completed a Series B funding round raising RMB 2.2 billion, indicating significant investor confidence in the EV/automotive manufacturing sector.
XPeng Inc. raised $300 million from multiple investors including Morningside Venture Capital, indicating significant funding for the autonomous/electric vehicle company at growth stage.
Epigenic Therapeutics raised $20M in Series Angel and Pre-A funding to develop next-generation gene editing therapies, indicating investor confidence in their therapeutic approach.